Analyst Profile

Followed by 60 followers
.
Michael Petusky

Michael Petusky

Barrington
Wall Street Analyst
#943 out of 8,160 Wall Street Analysts
#2,015 out of 24,427 experts

Success Rate

51%
176 out of 347 transactions made a profit

Average Return

+7.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Michael Petusky's trades since 2012 and holding each position for 1 Year would result in 50.72% of your transactions generating a profit, with an average return of 7.3% per rating.

Stock Rating Distribution

482Ratings
82.78% Buy
16.60% Hold
0.62% Sell
Distribution of Michael Petusky's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Opko Health
(OPK)
Rating:Buy
Date:Mar 26, 2020 - Mar 26, 2021
Return:+223.10%
The most profitable rating made by Michael Petusky

Michael Petusky's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CHSI
Catalyst Health Solutions Inc
Feb 23, 2012
Hold
Downgraded
1Ratings
0.00%
Regional Health Properties
Aug 14, 2013
Buy
Assigned
$6.50
(141.64% Upside)
1Ratings
100%
+11.30%
HNGR
Hanger Orthopedic
Aug 08, 2014
Hold
Downgraded
1Ratings
0.00%
LKQ
Apr 25, 2016
Buy
Upgraded
$30.00
(-45.51% Downside)
1Ratings
0%
-10.00%
PMC
PharMerica Corp
Aug 03, 2017
Sell
Downgraded
5Ratings
60%
+14.22%
Rosetta Genomics
Dec 18, 2017
Hold
Downgraded
2Ratings
0%
-64.50%
~PRMW
Primo Water
Jan 14, 2020
Hold
Downgraded
27Ratings
60%
+11.59%
VAR
Varian Medical Systems
Jan 28, 2021
Sell
Reiterated
21Ratings
72%
+12.57%
MP Materials
Jun 09, 2021
Buy
Initiated
1Ratings
100%
+14.20%
TVTY
Tivity Health
Jun 10, 2022
Hold
Reiterated
37Ratings
58%
+21.28%
List of latest recommendations made by Michael Petusky. Click to expand and see Michael Petusky's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >